Analysis of the Global Vaccines Delivery Market

Innovative Technologies and Future Trends for Stakeholders

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
13-Mar-2015
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P875-01-00-00-00
SKU
LS00151-AP-MR_16992
Yes
SHARE

Analysis of the Global Vaccines Delivery Market
Published on: 13-Mar-2015 | SKU: LS00151-AP-MR_16992

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immunization more costly and less safe, particularly in resource-poor developing countries. More than 120 new products are currently in the development pipeline, of which sixty hold significant importance to developing nations. The type of delivery system will predict which type of vaccine delivery will remain the most attractive (in terms of revenue) for stakeholders in the next 5 years.

Key Findings

Key Findings (continued)

Key Findings—Options in the Global Vaccine Delivery Market

Unmet Needs in the Global Vaccine Delivery Market

Scope and Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

Market Engineering Measurements (continued)

CEO’s Perspective

Key Companies to Watch

Key Companies to Watch (continued)

3 Key Predictions

Market Background

Market Segmentation

Segmentation by Type of Delivery

Segmentation by Region and Top 10 Vaccine Product Sales in 2013

Segmentation by Top 5 Competitors

New Market Opportunities

Pipeline of Vaccine Delivery Systems

Attractiveness in Vaccine Delivery Market

Market Drivers

Drivers Explained

Market Restraints

Restraints Explained

Market Engineering Measurements

Forecast Assumptions and Definitions

Revenue Forecast

Revenue Forecast by Segment

Revenue Forecast Discussion

Injectable Vaccine Delivery Market Highlights

High Potential Segment for Injectable Vaccine Delivery—Influenza (Flu)

Key Vaccine Companies (Private)

Porter’s Five Force Analysis

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Injectable Vaccine Delivery System Expected to Remain in Demand—Results of Recent Survey

Competitive Assessment

Injectable Vaccine With Promising Future—Pneumococcal Vaccine (PCV13)

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Competitive Assessment

Market Engineering Measurements

Revenue Forecast

Competitive Assessment

Other Vaccine Deliveries with Promising Future—Intranasal Flu Spray

Global—Polio Vaccine Trends

India—Polio Vaccine Trends

The United States—New Vaccine Technology

Europe—New Vaccine Technology

Other Regions (APAC)—New Vaccine Technology

Becton Dickinson and Company (BD)

BioCSL

Novavax Inc.

Vaxart Inc.

Vaxxas

Future of Vaccine Delivery Systems

Key Conclusions

Frost & Sullivan Awards

Legal Disclaimer

Market Engineering Methodology

Learn More—Next Steps


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immunization more costly and less safe, particularly in resource-poor developing countries. More than 120 new products are currently in the development pipeline, of which sixty hold significant importance to developing nations. The type of delivery system will predict which type of vaccine delivery will remain the most attractive (in terms of revenue) for stakeholders in the next 5 years.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Siddharth Dutta
WIP Number P875-01-00-00-00
Is Prebook No

Analysis of the Global Vaccines Delivery Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00151-AP-MR_16992